Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics
Werte in diesem Artikel
For the quarter ended September 2025, Encompass Health (EHC) reported revenue of $1.48 billion, up 9.4% over the same period last year. EPS came in at $1.23, compared to $1.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.48 billion, representing a surprise of +0.05%. The company delivered an EPS surprise of +3.36%, with the consensus EPS estimate being $1.19.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net patient revenue per discharge: $21,679.00 compared to the $21,612.91 average estimate based on two analysts.Discharges: 65,839 compared to the 66,576 average estimate based on two analysts.Net Operating Revenues- Net patient revenue- Inpatient: $1.43 billion versus $1.44 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.4% change.Net Operating Revenues- Net patient revenue- Outpatient and other: $50.2 million compared to the $42.58 million average estimate based on two analysts. The reported number represents a change of +44.3% year over year.View all Key Company Metrics for Encompass Health here>>>Shares of Encompass Health have returned -5.5% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Encompass Health Corporation (EHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Encompass Health
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Encompass Health
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Encompass Holdings Inc
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Encompass Holdings Inc
Keine Analysen gefunden.